Valuation: Medicamen Biotech Limited

Capitalization 499.49Cr 5.53Cr 4.75Cr 4.43Cr 4.12Cr 7.68Cr 8.29Cr 51Cr 20Cr 238.7Cr 21Cr 20Cr 880.34Cr P/E ratio 2024
44.4x
P/E ratio 2025 86.2x
Enterprise value 529.51Cr 5.86Cr 5.04Cr 4.7Cr 4.37Cr 8.15Cr 8.78Cr 54Cr 21Cr 253.04Cr 22Cr 22Cr 933.24Cr EV / Sales 2024
2.81x
EV / Sales 2025 3.83x
Free-Float
40.47%
Yield 2024
0.26%
Yield 2025 0.21%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.87%
1 week-2.48%
Current month+6.18%
1 month-3.02%
3 months+26.08%
6 months+0.43%
Current year+6.18%
More quotes
1 week 373.2
Extreme 373.2
405
1 month 354
Extreme 354
454
Current year 361.25
Extreme 361.25
454
1 year 292.5
Extreme 292.5
560
3 years 292.5
Extreme 292.5
903.5
5 years 292.5
Extreme 292.5
1,219
10 years 38.65
Extreme 38.65
1,219
More quotes
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - -
Compliance Officer - 12/02/2018
Director TitleAgeSince
Director/Board Member 61 08/01/2010
Director/Board Member 80 31/12/2015
Director/Board Member 71 31/12/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.87%-2.48%-20.33%-53.71% 5.53Cr
-1.62%-4.59%-3.96%+64.25% 4.59TCr
+2.30%-0.26%+57.24% - 3.18TCr
-0.40%+2.54%+13.75%+126.24% 3.05TCr
-0.95%-2.28%-0.92%+35.38% 1.3TCr
-1.88%-4.72%-11.64%+101.26% 1TCr
+2.05%+8.44%+89.58%+51.37% 874.93Cr
+0.92%+4.29%+55.32%+123.47% 776.41Cr
-.--%+0.14% - - 678.76Cr
+1.02%+3.25%+39.72%-20.64% 667.63Cr
Average -0.05%+1.67%+24.31%+53.45% 1.61TCr
Weighted average by Cap. -0.10%+0.41%+22.06%+77.80%
See all sector performances

Financials

2024 2025
Net sales 179.31Cr 1.99Cr 1.71Cr 1.59Cr 1.48Cr 2.76Cr 2.97Cr 18Cr 7.19Cr 86Cr 7.45Cr 7.29Cr 316.02Cr 167.55Cr 1.86Cr 1.59Cr 1.49Cr 1.38Cr 2.58Cr 2.78Cr 17Cr 6.72Cr 80Cr 6.96Cr 6.81Cr 295.3Cr
Net income 11Cr 12.1L 10.4L 10L 9L 16.82L 18.13L 1.11Cr 43.81L 5.22Cr 45.39L 44.46L 19Cr 7.11Cr 8L 7L 6L 6L 10.93L 11.79L 72.51L 28.49L 3.4Cr 29.52L 28.91L 13Cr
Net Debt 16Cr 18.08L 15.53L 14.49L 13.46L 25.11L 27.08L 1.67Cr 65.43L 7.8Cr 67.79L 66.4L 29Cr 30Cr 33.23L 28.56L 26.63L 24.75L 46.17L 49.79L 3.06Cr 1.2Cr 14Cr 1.25Cr 1.22Cr 53Cr
More financial data * Estimated data
Logo Medicamen Biotech Limited
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in research and development, manufacturing, marketing, and distribution of pharmaceutical products. The Company manufactures products across various therapeutic categories, including Pain Management, Cough and Cold, Cardiovascular and Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic, among others. The Company manufactures a range of products, including tablets, capsules, dry syrup, non-beta lactum, ointments, and creams. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Letrozole, Melphalan, Oxaliplatin, Pazopanib, Its Cardiology products include Nifedipine Capsules, Atorvastatin Tablets, Fenofibrate Capsules, Rosuvastatin Tablets.
Employees
376
More about the company
Date Price Change Volume
14/26/14 385.50 -1.87% 177
13/26/13 392.85 -0.57% 766
12/26/12 395.10 +1.26% 2,381
09/26/09 390.20 -2.45% 165
08/26/08 400.00 +1.19% 3,256

Delayed Quote Bombay S.E., January 14, 2026 at 03:30 pm IST

More quotes
  1. Stock Market
  2. Equities
  3. MEDICAMEQ Stock